Ask AI

Putting Blood-Based Biomarkers to Work in Alzheimer’s Care

Blood-based biomarkers are transforming the diagnostic landscape of Alzheimer's disease by offering less invasive approaches to identifying underlying pathology. Learners will review current evidence for established and emerging blood-based biomarkers, including phosphorylated tau and amyloid-beta 42/40 ratios, and explore their clinical utility, interpretation, and integration into diagnostic workflows and treatment decision-making.

Share

Program Content

Events

Activities

Biomarkers in Alzheimer’s Care
Putting Blood-Based Biomarkers to Work in Alzheimer’s Care
Slideset
Congratulations: You achieved a completion on 04/09/2022

Released: October 21, 2026

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC dba Decera Clinical Education.